View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AA99 | Publication ID: Fall 2008 |
Title: Changes to Patient Limitation for Dispensing or Prescribing Approved Narcotic Controlled Substances for Maintenance or Detoxification Treatment by Qualified Individual Practitioners | |
Abstract: DEA is amending its regulations to remove the group practice limitation for practitioners who dispense or prescribe certain narcotic drugs for maintenance treatment or detoxification treatment. This change will make the DEA regulations consistent with recent changes to the Controlled Substances Act that removed the patient limitation on prescribing drug addiction treatments by practitioners in group practices. DEA is also amending its regulations to permit certain qualifying physicians to dispense and prescribe narcotic controlled substances in maintenance or detoxification treatment to up to 100 patients at any one time, after the practitioner submits to the Secretary of the Department of Health and Human Services a notification of the practitioners need and intent to treat the increased number of patients. | |
Agency: Department of Justice(DOJ) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Completed Actions |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 1301 | |
Legal Authority: 21 USC 821 21 USC 822 21 USC 823 21 USC 824 21 USC 871 (b) 21 USC 875 21 USC 877 |
Legal Deadline:
None |
|||||||||||||||
Timetable:
|
Additional Information: Docket DEA-275 | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Information URL: www.regulations.gov | |
RIN Data Printed in the FR: No | |
Agency Contact: Mark W. Caverly Chief, Liaison and Policy Section Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Springfield, VA 22152 Phone:202 307-7297 Email: dea.diversion.policy@usdoj.gov |